Archives

Walgreens To Buy $970M Majority Stake In Specialty Pharmacy Developer 204 115 Shields Health Solutions

Walgreens To Buy $970M Majority Stake In Specialty Pharmacy Developer

Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…

Walgreens Boots Alliance Makes Majority Investment in Shields Health Solutions, Expanding Position in Fast-Growing Specialty Pharmacy Market 204 115 Shields Health Solutions

Walgreens Boots Alliance Makes Majority Investment in Shields Health Solutions, Expanding Position in Fast-Growing Specialty Pharmacy Market

DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…

Walgreens Boots takes a controlling stake in Shields Health Solutions 204 115 Shields Health Solutions

Walgreens Boots takes a controlling stake in Shields Health Solutions

The company will pay $970 million to increase its ownership of the Stoughton-based specialty pharmacy company to 71 percent

Excelera® and Aptitude Health Offer New Specialty Pharmacy Focused Educational Resources for Cancer Care 204 115 Shields Health Solutions

Excelera® and Aptitude Health Offer New Specialty Pharmacy Focused Educational Resources for Cancer Care

MINNEAPOLIS–(BUSINESS WIRE)–Excelera®, a wholly-owned subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today a new specialty pharmacy-focused educational offering in partnership with Aptitude Health, which provides critical insights…

Excelera Network Welcomes Kettering Health 204 115 Shields Health Solutions

Excelera Network Welcomes Kettering Health

MINNEAPOLIS–(BUSINESS WIRE)–Kettering Health has entered an agreement with Excelera®, a wholly-owned subsidiary of Shields Health Solutions and the company behind the Excelera Network, making it the first Excelera Network member in…

Study Shows Shields Health Solutions Integrated Specialty Pharmacy Model Significantly Reduces Total Cost of Care 204 115 Shields Health Solutions

Study Shows Shields Health Solutions Integrated Specialty Pharmacy Model Significantly Reduces Total Cost of Care

BOSTON, April 20, 2021 /PRNewswire/ — Shields Health Solutions (Shields), the leading health system specialty pharmacy integrator, announced today the results of a joint study with Optum Advisory Services that…

Excelera Network Welcomes Rush University Medical Center to Optimize and Innovate Specialty Pharmacy Services 204 115 Shields Health Solutions

Excelera Network Welcomes Rush University Medical Center to Optimize and Innovate Specialty Pharmacy Services

MINNEAPOLIS, MN, December 21, 2020 — Rush University Medical Center (RUMC) has partnered with Excelera®, the company behind the Excelera Network, making it the second Excelera Network member in the…

Meet HOSP: The Health System Owned Specialty Pharmacy Alliance 1024 576 Shields Health Solutions

Meet HOSP: The Health System Owned Specialty Pharmacy Alliance

Much like us at Shields Health Solutions, the fully integrated specialty pharmacies market is growing rapidly. It became clear that there needed to be a trade organization committed to advocating…

JAMA Network Open Reports Specialty Pharmacy Partnership Between Shields Health Solutions and UMass Memorial Medical Center Yields Significant Reduction in Total Cost of Care for Patients Filling Prescriptions at Hospital Pharmacy 843 317 Shields Health Solutions

JAMA Network Open Reports Specialty Pharmacy Partnership Between Shields Health Solutions and UMass Memorial Medical Center Yields Significant Reduction in Total Cost of Care for Patients Filling Prescriptions at Hospital Pharmacy
An article published n the Journal of the American Medical Association (JAMA) Network Open, a three-year study (2016-2018) revealed that patients living with chronic illnesses such as cancer, transplants, rheumatoid arthritis, and other diseases were associated with significantly lower total medical expenditure when filling their prescriptions at the hospital’s own specialty pharmacy, rather than using an outside specialty pharmacy.
ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit 204 115 Shields Health Solutions

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector